skip to main content

Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon

Cantrell, Christopher ; Reid, Conor ; Walker, Claudia S ; Stallkamp Tidd, Samantha J ; Zhang, Ryan ; Wilson, Robert

Frontiers in neurology, 2024, Vol.15, p.1297964-1297964 [Periódico revisado por pares]

Switzerland: Frontiers Media S.A

Texto completo disponível

Citações Citado por
  • Título:
    Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon
  • Autor: Cantrell, Christopher ; Reid, Conor ; Walker, Claudia S ; Stallkamp Tidd, Samantha J ; Zhang, Ryan ; Wilson, Robert
  • Assuntos: autonomic ; COVID ; neurology ; orthostatic ; post-COVID ; POTS
  • É parte de: Frontiers in neurology, 2024, Vol.15, p.1297964-1297964
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: The impact of COVID-19 has been far-reaching, and the field of neurology is no exception. Due to the long-hauler effect, a variety of chronic health consequences have occurred for some post-COVID patients. A subset of these long-hauler patients experienced symptoms of autonomic dysfunction and tested positive for postural orthostatic tachycardia syndrome (POTS) via autonomic testing. We conducted a chart review of a convenience sample from patients seen by neurologists at our tertiary care center for suspicion of post-COVID POTS. Patients included in our study had clearly defined POTS based on clinical criteria and positive tilt table test, were 81.25% female, and had an average age of approximately 36. Out of 16 patients, 12 had a confirmed positive COVID test result, with the remaining 4 having strong clinical suspicion for COVID infection. Our analysis examined the most bothersome 3 symptoms affecting each patient per the neurologist's note at their initial visit for post-COVID POTS, clinical presentation, comorbidities, neurological exam findings, autonomic testing results, and COMPASS-31 autonomic questionnaire and PROMIS fatigue survey results. Palpitations (68.75%) and fatigue (62.5%) were the most common of the impactful symptoms reported by patients in their initial Cleveland Clinic neurology visit. The most frequent comorbidities in our sample were chronic migraines (37.5%), irritable bowel syndrome (IBS) (18.75%), and Raynaud's (18.75%). Neurological exam findings and autonomic testing results other than tilt table yielded variable findings without clear trends. Survey results showed substantial autonomic symptom burden (COMPASS-31 autonomic questionnaire average score 44.45) and high levels of fatigue (PROMIS fatigue survey average score 64.64) in post-COVID POTS patients. Our sample of post-COVID POTS patients are similar to the diagnosed POTS general population including in comorbidities and autonomic testing. Fatigue was identified by patients as a common and debilitating symptom. We hope that our study will be an early step toward further investigation of post-COVID POTS with focus on the trends identified in this chart review.
  • Editor: Switzerland: Frontiers Media S.A
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.